Download PDF
Thromb Haemost 1988; 59(02): 346-347
DOI: 10.1055/s-0038-1642794
letter to editor
Schattauer GmbH Stuttgart

Relevance of Free tPA Assay Following Venous Occlusion in Patients with Venous Thromboembolic Disease

M C Alessi
1   Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium
,
I Juhan-Vague
1   Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium
,
J Valadier
1   Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium
,
C Philip Joet
1   Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium
,
P Holvoet
2   Center for Thrombosis and Vascular Research, Leuven, Belgium
,
D Collen
1   Laboratory of Hematology, CHU Timone, Marseille, France, Leuven, Belgium
› Author Affiliations
Further Information

Publication History

Received 08 December 1987

Accepted after revision 28 December 1987

Publication Date:
21 May 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Brommer EJ P, Verheijen JH, Chang GT G, Rijken DC. Masking offibrinolytic response to stimulation by an inhibitor of tissue-typeplasminogen activator in plasma. Thromb Haemostas 1984; 52: 154-156
    PubMedGoogle Scholar
  • 2 Nilsson IM, Ljungner H, Tengborn L. Two different mechanisms inpatients with venous thrombosis and defective fibrinolysis: low concen-tration of plasminogen activator and increased concentration of plas-minogen activator inhibitor. Brit Med J 1985; 290: 1453-1455
    CrossrefPubMedGoogle Scholar
  • 3 Stalder M, Hauert Y, Kruithof EK O, Bachmann F. Release ofvascular plasminogen activator (t-PA) after venous stasis: Elec-trophoretic zymographic analysis of free and complexed tPA. Brit JHaematol 1985; 61: 169-176
    PubMedGoogle Scholar
  • 4 Juhan-Vque I, Valadier J, Aiessi MC, Aillaud MF, Ansaldi J, Philip-Joet C, Holvoet P, Serradirnigni A, Colien D. Deficient tPA release and elevated PA inhibitor levels in patients with spontaneous or recurrcnr deep venous thrombosis. Thromb Haernostai 1987; 57: 67-72
    PubMedGoogle Scholar
  • 5 Holvoet P, Boes J, Coilen D. Measurenient of free, one-chain tissue type piasniinogen activator in human plasma with an enzyme-linked immunosorbent assay based on an active site speciflc murine monoclonal antibody. Blood 1987; 69: 281-9
    PubMedGoogle Scholar
  • 6 Kluft C, Brakman P, Veldhuyzen-Stolk EC. Screening of fihrinolytic activit) in plasma euplobuiin fraction on the fibrin plate. In Progress in Chemical Fihrinolysis and Thrombosis. Davidson IF, Samama MM, Desnoyers PC. (Eds). vol II pp 57-65 Raven Press; New York: 1976
  • 7 Verheijen JH, Chang GT G, Kluft C. Evidence for the occurrence of a fast acting inhibitor for tissue-type plasrninogen activator in human plasma. Thromb Haemostas 1984; 51: 392-5
    PubMedGoogle Scholar
  • 8 Gaffncy PJ, Curtis AD. A coiiaborativc study of a proposed international standard for tissue plasminogen activator (tPA). Thromb Haernostas 1985; 53: 134-6
    PubMedGoogle Scholar
  • 9 Holvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (tPA) with an enzyne-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA. Thromb Haemostas 1985; 54: 684-7
    PubMedGoogle Scholar